title: Intense pulsed light therapy for the treatment of evaporative dry eye disease.
abstract: OBJECTIVE
  Evaporative dry eye disease is one of the most common types of dry eye. It is often the result of chronic meibomian gland dysfunction (MGD) and associated ocular rosacea. Evaporative dry eye and MGD significantly reduce patient's quality of life. Traditional treatments, such as artificial tears, warm compresses, and medications, such as topical cyclosporine, azithromycin, and oral doxycycline, provide some relief; however, many patients still suffer from dry eye symptoms. Intense pulsed light (IPL) therapy, which has been used extensively in dermatology to treat chronic skin conditions, is a relatively new treatment in ophthalmology for patients with evaporative dry eye disease.
  
  
  RESULTS
  There are very few studies published on the use of IPL in patients with dry eye disease. The present review describes the theoretical mechanisms of IPL treatment of MGD and ocular rosacea. Personal clinical experience and recently presented data are reported as well.
  
  
  CONCLUSIONS
  IPL therapy has promising results for evaporative dry eye patients. There are statistically significant improvements in clinical exam findings of dry eye disease. More importantly, patients report subjective improvement in their symptoms. More research is needed in this area to help understand the mechanism of dry eye disease and how it can be effectively treated.
authors.affiliation: Department of Ophthalmology, Cornea, External Disease, and Refractive Surgery, Duke Eye Center, Durham, North Carolina, USA.
authors.forename: Gargi K
authors.initials: GK
authors.lastname: Vora
authors.forename: Preeya K
authors.initials: PK
authors.lastname: Gupta
mesh_terms: D015352:Dry Eye Syndromes / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005141:Eyelid Diseases / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D062325:Intense Pulsed Light Therapy; D008537:Meibomian Glands / Q000473:pathology*; D012393:Rosacea / Q000150:complications / Q000175:diagnosis / Q000628:therapy*